Clinical Trials Logo

Clinical Trial Summary

The objective of this research is to determine if the addition of the Clear Guide ONE, a Computer Assisted Instrument Guidance (CAIG) system, provides improvement over existing ultrasound guided, needle-based procedures for peripheral nerve blocks. The ultrasound can visualize the targeted vessel or nerve, but the addition of the CAIG may help the clinician better guide the needle to the target.


Clinical Trial Description

This pilot study will be a randomized, single-blinded control trial. The clinicians cannot be blinded, but the person questioning the patient post-op to determine success rate will be blinded. There will be two randomized groups of patients: control and test. The control group will receive the procedure with traditional methods and equipment currently in use at Cooper University. The test group will receive the same procedure utilizing existing ultrasound equipment with the supplemental CAIG system. ;


Study Design

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Outcomes Assessor), Primary Purpose: Supportive Care


Related Conditions & MeSH terms


NCT number NCT02614222
Study type Interventional
Source Clear Guide Medical
Contact Ronak Desai, DO
Phone 856-342-2000
Email desai-ronak@cooperhealth.edu
Status Recruiting
Phase N/A
Start date November 2015
Completion date August 2016

See also
  Status Clinical Trial Phase
Recruiting NCT06418100 - Recto-intercostal Block for Coronary Artery Bypass Grafting N/A
Completed NCT05073055 - Spinal Anesthesia Versus Erector Spina Plane Block N/A